Raffa Wealth Management’s United Therapeutics UTHR Stock Holding History

Raffa Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Buy	2 +1	+100%	+$563	﹤0.01%	995
2026 Q1	$593	Buy	+1	New	+$498	﹤0.01%	1046
2022 Q3	–	Sell	-2	Closed	-$471	–	1202
2022 Q2	$471	Hold	2	–	–	﹤0.01%	1030
2022 Q1	$359	Buy	+2	New	+$381	﹤0.01%	1087
2021 Q4	–	Sell	-1	Closed	-$185	–	1148
2021 Q3	$185	Hold	1	–	–	﹤0.01%	1107
2021 Q2	$179	Sell	1 -3	-75%	-$571	﹤0.01%	1084
2021 Q1	$669	Buy	+4	New	+$667	﹤0.01%	978
2016 Q3	–	Sell	-6	Closed	-$636	–	886
2016 Q2	$636	Hold	6	–	–	﹤0.01%	579
2016 Q1	$669	Hold	6	–	–	﹤0.01%	550
2015 Q4	$940	Hold	6	–	–	﹤0.01%	407
2015 Q3	$787	Hold	6	–	–	﹤0.01%	458
2015 Q2	$1.04K	Hold	6	–	–	﹤0.01%	379
2015 Q1	$1.03K	Buy	+6	New	+$915	﹤0.01%	382
2014 Q2	–	Sell	-13	Closed	-$1.22K	–	285
2014 Q1	$1.22K	Buy	+13	New	+$1.33K	﹤0.01%	236

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Raffa Wealth Management's UTHR Position: Q2 2026 in Review

Raffa Wealth Management increased its United Therapeutics (UTHR) stake by 100% in Q2 2026, buying an estimated $563 and bringing the position to 2 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Raffa Wealth Management first reported a position in UTHR in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.22K in Q1 2014. 818 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Raffa Wealth Management held 2 shares of United Therapeutics worth $1.08K as of Q2 2026.
Raffa Wealth Management bought 1 United Therapeutics share in Q2 2026, an estimated $563.
United Therapeutics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #995 holding.
Raffa Wealth Management first reported a position in United Therapeutics in Q1 2014 and has held it in 14 quarters since.
Raffa Wealth Management's United Therapeutics position peaked at $1.22K in Q1 2014.
818 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.